AIH vs. CDIO, PLAG, TLIS, VINC, FLGC, TRAW, PMD, PPBT, KPRX, and MIRA
Should you be buying Aesthetic Medical International Holdings Group stock or one of its competitors? The main competitors of Aesthetic Medical International Holdings Group include Cardio Diagnostics (CDIO), Planet Green (PLAG), Talis Biomedical (TLIS), Vincerx Pharma (VINC), Flora Growth (FLGC), Traws Pharma (TRAW), Psychemedics (PMD), Purple Biotech (PPBT), Kiora Pharmaceuticals (KPRX), and MIRA Pharmaceuticals (MIRA). These companies are all part of the "medical" sector.
Aesthetic Medical International Holdings Group (NASDAQ:AIH) and Cardio Diagnostics (NASDAQ:CDIO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, media sentiment, profitability, valuation, dividends, analyst recommendations, risk and community ranking.
Aesthetic Medical International Holdings Group has a net margin of 0.00% compared to Cardio Diagnostics' net margin of -34,911.87%. Aesthetic Medical International Holdings Group's return on equity of 0.00% beat Cardio Diagnostics' return on equity.
2.1% of Aesthetic Medical International Holdings Group shares are owned by institutional investors. Comparatively, 8.1% of Cardio Diagnostics shares are owned by institutional investors. 55.1% of Aesthetic Medical International Holdings Group shares are owned by company insiders. Comparatively, 30.0% of Cardio Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Aesthetic Medical International Holdings Group has a beta of -0.21, indicating that its stock price is 121% less volatile than the S&P 500. Comparatively, Cardio Diagnostics has a beta of 5.3, indicating that its stock price is 430% more volatile than the S&P 500.
In the previous week, Aesthetic Medical International Holdings Group and Aesthetic Medical International Holdings Group both had 3 articles in the media. Aesthetic Medical International Holdings Group's average media sentiment score of 1.70 beat Cardio Diagnostics' score of 0.69 indicating that Aesthetic Medical International Holdings Group is being referred to more favorably in the media.
Cardio Diagnostics received 1 more outperform votes than Aesthetic Medical International Holdings Group when rated by MarketBeat users. Likewise, 66.67% of users gave Cardio Diagnostics an outperform vote while only 33.33% of users gave Aesthetic Medical International Holdings Group an outperform vote.
Aesthetic Medical International Holdings Group has higher revenue and earnings than Cardio Diagnostics.
Cardio Diagnostics has a consensus target price of $1.35, indicating a potential upside of 96.51%. Given Cardio Diagnostics' higher probable upside, analysts plainly believe Cardio Diagnostics is more favorable than Aesthetic Medical International Holdings Group.
Summary
Aesthetic Medical International Holdings Group and Cardio Diagnostics tied by winning 7 of the 14 factors compared between the two stocks.
Get Aesthetic Medical International Holdings Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for AIH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AIH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aesthetic Medical International Holdings Group Competitors List
Related Companies and Tools
